For entities preparing to undertake an listing, stringent adherence to Good Manufacturing Practices (cGMP) is paramount. Regulatory bodies, such as the FDA, increasingly scrutinize applicant's manufacturing processes to validate product quality and patient safety. Failure to demonstrate robust GMP compliance can lead to postponements in the listing